Quantcast

Posts related to ‘FDA panel’

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday's decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels ...
Read Full Story »